Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Probiotics in Gastric Cancer
NCT05901779Unknown
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Apr 2023
- Primary completion
- Mar 2024
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, open-label trial of bifidobacterium longum and lactobacillus acidophilus in gastric cancer (GC) (2 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoint: Postoperative infectious complications. Status: unknown.
02
Drugs
bifidobacterium longumlactobacillus acidophilus
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT05901779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05901779.